AMGN vs PAYS · P/E 24, rev $10.05B vs P/E 43, rev $56.3M
Amgen Inc (AMGN) versus Paysign Inc (PAYS) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Paysign Inc (PAYS) is a software - infrastructure company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported PAYS revenue for 2026-06-30 was $56.3M. Net income was $12.2M. PAYS currently screens at market cap $407.6M and trailing P/E 42.9.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. PAYS currently screens at market cap $407.6M and trailing P/E 42.9.
Not investment advice. Open the AMGN and PAYS stock pages for the full models.
Not investment advice.